1. Gersuk GM, Beckham C, Loken MR, et al. A role for tumour necrosis factor-3, Fas and Fas-Ligand in marrow failure associated with myelodysplastic syndrome. Br J Haematol. 1998;103:176-188.
2. Li X, Pu Q, Liu Y, et al. Study on apoptosis in myelodysplastic syndromes by DNA in situ end labelling combined with APAAP [in Chinese]. Zhonghua Xue Ye Xue Za Zhi. 2002;23:27-29.
3. Bogdanovic AD, Jankovic GM, Colovic MD, Trpinac DP, Bum-basirevic VZ. Apoptosis in bone marrow of myelodysplastic syndrome patients [letter]. Blood. 1996;87:3064.
4. Tsoplou P, Kouralki-Symeonidis A, Thanopoulou E, Orphanos V, Zoumbos N. Apoptosis in patients with myelodysplastic syndromes (MDS): differential involvement of marrow cells in early versus advanced cases and correlation with the expression of apoptosis-related genes [abstract]. Blood. 1997;90(suppl 1):203a.Abstract 895.
5. Kliche KO, Andreeff M. High expression of phosphatidylserine (PS) in MDS, secondary AML (sAML) and normal progenitors: comparison with primary AML (pAML) [abstract]. Blood. 1997; 90(suppl 1):202a. Abstract 891.